Literature DB >> 22579285

Hsp90 globally targets paused RNA polymerase to regulate gene expression in response to environmental stimuli.

Ritwick Sawarkar1, Cem Sievers, Renato Paro.   

Abstract

The molecular chaperone Heat shock protein 90 (Hsp90) promotes the maturation of several important proteins and plays a key role in development, cancer progression, and evolutionary diversification. By mapping chromatin-binding sites of Hsp90 at high resolution across the Drosophila genome, we uncover an unexpected mechanism by which Hsp90 orchestrates cellular physiology. It localizes near promoters of many coding and noncoding genes including microRNAs. Using computational and biochemical analyses, we find that Hsp90 maintains and optimizes RNA polymerase II pausing via stabilization of the negative elongation factor complex (NELF). Inhibition of Hsp90 leads to upregulation of target genes, and Hsp90 is required for maximal activation of paused genes in Drosophila and mammalian cells in response to environmental stimuli. Our findings add a molecular dimension to the chaperone's functionality with wide ramifications into its roles in health, disease, and evolution.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579285     DOI: 10.1016/j.cell.2012.02.061

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  59 in total

1.  Gene expression: More roles and details for polymerase pausing.

Authors:  Darren J Burgess
Journal:  Nat Rev Genet       Date:  2012-05-29       Impact factor: 53.242

Review 2.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 3.  Hsp90 in Cancer: Transcriptional Roles in the Nucleus.

Authors:  Stuart K Calderwood; Len Neckers
Journal:  Adv Cancer Res       Date:  2015-10-12       Impact factor: 6.242

4.  HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade.

Authors:  Y J Kim; C B Greer; K R Cecchini; L N Harris; D P Tuck; T H Kim
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

Review 5.  Toxoplasma gondii Hsp90: potential roles in essential cellular processes of the parasite.

Authors:  Sergio O Angel; Maria J Figueras; Maria L Alomar; Pablo C Echeverria; Bin Deng
Journal:  Parasitology       Date:  2014-02-21       Impact factor: 3.234

Review 6.  Pervasive robustness in biological systems.

Authors:  Marie-Anne Félix; Michalis Barkoulas
Journal:  Nat Rev Genet       Date:  2015-08       Impact factor: 53.242

Review 7.  Molecular chaperones in the brain endothelial barrier: neurotoxicity or neuroprotection?

Authors:  Dominique Thuringer; Carmen Garrido
Journal:  FASEB J       Date:  2019-07-26       Impact factor: 5.191

Review 8.  It's not magic - Hsp90 and its effects on genetic and epigenetic variation.

Authors:  Rebecca A Zabinsky; Grace Alexandria Mason; Christine Queitsch; Daniel F Jarosz
Journal:  Semin Cell Dev Biol       Date:  2018-06-06       Impact factor: 7.727

9.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

10.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor.

Authors:  Camilla L Christensen; Nicholas Kwiatkowski; Brian J Abraham; Julian Carretero; Fatima Al-Shahrour; Tinghu Zhang; Edmond Chipumuro; Grit S Herter-Sprie; Esra A Akbay; Abigail Altabef; Jianming Zhang; Takeshi Shimamura; Marzia Capelletti; Jakob B Reibel; Jillian D Cavanaugh; Peng Gao; Yan Liu; Signe R Michaelsen; Hans S Poulsen; Amir R Aref; David A Barbie; James E Bradner; Rani E George; Nathanael S Gray; Richard A Young; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.